Profile data is unavailable for this security.
About the company
TYK Medicines Inc is a China-based company mainly engaged in developing and commercializing pharmaceutical products. The Company is primarily focused on small molecule drug development, and its main products include TY-9591, TY-302 and TY-2136. TY-9591 is a third-generation EGFR-TKI with antitumor effects on EGFR mutations. TY-302 is a potent, selective oral CDK4/6 inhibitor developed for the treatment of advanced solid tumors, including breast cancer and prostate cancer. TY-2136b is an internally developed, oral ROS1/NTRK inhibitor for the treatment of solid tumors.
- Revenue in HKD (TTM)0.00
- Net income in HKD-460.24m
- Incorporated2017
- Employees144.00
- LocationTYK Medicines Inc500 Yunjin Road, Greenland VilSHANGHAI 200030ChinaCHN
- Phone+86 2 161676766
- Fax+86 2 160107317
- Websitehttp://www.tykmedicines.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Frontage Holdings Corp | 2.02bn | 47.44m | 2.12bn | 1.66k | 45.33 | 0.8088 | 6.27 | 1.05 | 0.0229 | 0.0229 | 0.9873 | 1.29 | 0.4701 | 56.23 | 4.58 | 1,149,546.00 | 1.06 | 4.46 | 1.30 | 5.28 | 28.56 | 34.00 | 2.26 | 9.92 | 1.25 | 2.37 | 0.311 | 0.00 | 3.79 | 25.61 | -58.00 | -0.7826 | 40.43 | -- |
| Biocytogen Pharmaceuticals Beijng Co Ltd | 861.01m | -262.22m | 2.30bn | 1.04k | -- | 2.89 | -- | 2.67 | -0.6584 | -0.6584 | 2.16 | 1.99 | 0.3109 | 23.64 | 5.36 | 807,697.60 | -9.47 | -- | -12.44 | -- | 71.97 | -- | -30.46 | -- | 1.33 | -4.18 | 0.436 | -- | 34.28 | -- | 36.38 | -- | -- | -- |
| CStone Pharmaceuticals | 490.99m | -153.05m | 2.34bn | 164.00 | -- | 4.65 | -- | 4.76 | -0.1201 | -0.1201 | 0.3851 | 0.3917 | 0.2861 | 1.33 | 2.50 | 2,134,756.00 | -8.92 | -54.76 | -16.99 | -81.68 | 70.73 | -- | -31.17 | -301.62 | 1.45 | -- | 0.4171 | -- | -3.64 | -- | 59.32 | -- | 52.42 | -- |
| Qyuns Therapeutics Co Ltd | 48.31m | -453.64m | 2.89bn | 325.00 | -- | 7.30 | -- | 59.76 | -1.93 | -1.93 | 0.2193 | 1.78 | -- | -- | -- | 145,950.60 | -- | -- | -- | -- | 84.05 | -- | -976.77 | -- | 1.83 | -29.56 | 0.5795 | -- | -- | -- | -70.28 | -- | -- | -- |
| Abbisko Cayman Ltd | 534.81m | -17.42m | 3.02bn | 275.00 | -- | 1.36 | 850.57 | 5.65 | -0.0295 | -0.0295 | 0.8235 | 3.28 | 0.2159 | -- | 65.75 | 2,072,904.00 | -0.7034 | -- | -0.733 | -- | 0.00 | -- | -3.26 | -- | -- | -- | 0.0142 | -- | -- | -- | 12.92 | -- | -- | -- |
| ImmuneOnco Biopharmaceuticls Shanghi Inc | 405.46k | -402.65m | 3.17bn | 150.00 | -- | 4.91 | -- | 7,816.15 | -1.12 | -1.12 | 0.0011 | 1.73 | -- | -- | -- | 2,796.26 | -- | -- | -- | -- | -- | -- | -99,307.43 | -- | -- | -- | 0.14 | -- | -28.25 | -- | 5.82 | -- | -- | -- |
| CARsgen Therapeutics Holdings Ltd | 6.82m | -747.33m | 4.17bn | 477.00 | -- | 2.61 | -- | 611.06 | -1.34 | -1.34 | 0.0122 | 2.80 | 0.0027 | -- | 0.302 | 13,214.28 | -29.27 | -- | -32.86 | -- | 25.50 | -- | -10,960.25 | -- | 9.44 | -- | 0.1246 | -- | -- | -- | 16.19 | -- | -- | -- |
| Alphamab Oncology | 275.18m | -231.90m | 4.33bn | 429.00 | -- | 2.48 | -- | 15.74 | -0.2409 | -0.2409 | 0.2858 | 1.82 | 0.1145 | 0.8256 | 13.94 | 632,607.10 | -9.65 | -18.72 | -11.16 | -21.94 | 79.33 | -- | -84.27 | -415.55 | 4.42 | -- | 0.167 | -- | 31.12 | -- | 35.35 | -- | -13.12 | -- |
| Laekna Inc | 0.00 | -317.84m | 4.44bn | 92.00 | -- | 6.10 | -- | -- | -0.8919 | -0.8919 | 0.00 | 1.86 | 0.00 | -- | -- | 0.00 | -31.46 | -- | -35.71 | -- | -- | -- | -- | -- | -- | -- | 0.0856 | -- | -- | -- | 52.81 | -- | -- | -- |
| Lepu Biopharma Co Ltd | 220.56m | -78.10m | 5.53bn | 491.00 | -- | 5.62 | 405.74 | 25.05 | -0.0463 | -0.0463 | 0.1325 | 0.5751 | 0.0847 | 1.86 | 1.53 | 514,131.50 | -3.53 | -- | -5.72 | -- | 78.76 | -- | -41.62 | -- | 0.7322 | -2.71 | 0.4621 | -- | 1,347.16 | -- | 96.79 | -- | -- | -- |
| TYK Medicines Inc | 0.00 | -460.24m | 9.09bn | 144.00 | -- | -- | -- | -- | -1.24 | -1.24 | 0.00 | -3.04 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -50.25 | -- | -- | -100.00 | -- | -22.97 | -- | -- | -- |
| Keymed Biosciences Inc | 87.82m | -799.16m | 11.58bn | 1.12k | -- | 4.08 | -- | 131.88 | -3.06 | -3.06 | 0.3359 | 10.14 | 0.0207 | 0.3115 | 7.74 | 97,900.21 | -18.86 | -- | -20.96 | -- | 68.65 | -- | -909.38 | -- | 4.83 | -- | 0.2155 | -- | 253.87 | -- | -16.63 | -- | -- | -- |
| Ascentage Pharma Group International | 971.19m | -387.48m | 12.94bn | 574.00 | -- | 15.67 | -- | 13.32 | -1.34 | -1.34 | 3.34 | 2.62 | 0.2998 | 3.49 | 2.19 | 1,665,855.00 | -11.97 | -44.93 | -16.78 | -57.04 | 96.96 | 87.68 | -39.93 | -976.10 | 1.83 | -8.16 | 0.6865 | -- | 5.85 | 100.76 | -4.84 | -- | 2.82 | -- |
Data as of Nov 14 2024. Currency figures normalised to TYK Medicines Inc's reporting currency: Hong Kong Dollar HKD
